Premium
[P1–151]: VEGFA IS ASSOCIATED WITH CEREBRAL BLOOD FLOW AND WHITE MATTER HYPERINTENSITY IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE
Author(s) -
Horgusluoglu Emrin,
Nho Kwangsik,
Risacher Shan L.,
Saykin Andrew J.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.218
Subject(s) - cerebral blood flow , hyperintensity , cardiology , alzheimer's disease neuroimaging initiative , neuroimaging , angiogenesis , white matter , vascular endothelial growth factor , medicine , pathology , psychology , single nucleotide polymorphism , magnetic resonance imaging , neuroscience , dementia , disease , genotype , biology , radiology , genetics , vegf receptors , gene
clauses can clarify that data will continue to be shared and used after a loss of capacity. Where individuals are unable to consent, we clarify processes and principles governing proxy decision making. A proxy is legally and ethically bound to respect the incapable adult’s best interests, including his or her previously expressed wishes; values and beliefs; and well-being. Conclusions: By removing consent barriers to sharing, we hope to show that international collaboration in dementia research is not only possible, it is imperative.